Effects of COVID-19 on evaluation of thyroid function in individuals with a history of hypothyroidism

A study was conducted in Pathankot district, India, investigating how COVID-19 affects people already suffering from hypothyroidism. This was a retrospective cross-sectional type of research that included 60 patients taking anti-hypothyroid treatment, and their thyroid function tests (TSH, T3, T4) were scrupulously analysed. The findings were dramatically variable for the levels of TSH that rose significantly, and that of T4 rose a little. These changes imply that the COVID-19 pandemic probably led to a disturbance in hypothyroidism management, most likely caused by stress, different kinds of access to health care, or probably medication adherence changed. Blood samples were analysed using advanced methods of chemiluminescent immunoassay and haematological analysers, hence guaranteeing the exact measurement of thyroid-related biochemical markers. Thyroid function, therefore, should be continuously monitored even during global health crises, as disturbances in regular care tend to bring about large fluctuations in the hormone levels. The results advocate for the implementation of adaptive health strategies, including using telemedicine to support patients consistently and mitigate the impacts of such disruptions. Such a study, therefore, identifies the critical need for enhanced patient care and monitoring in vulnerable populations with chronic conditions like hypothyroidism during a pandemic.